US-EN
Select Country

LATEST NEWS

First Approval by U.S. Food and Drug Administration for Contrast Enhanced Ultrasonography of the Liver Received by Bracco Diagnostics Inc. for LUMASON



Read more

 

As of 14 March 2016, Bracco Diagnostics Inc.'s U.S. Gastroenterology Business Unit proprietary product offerings have officially transferred to U.S. Endoscopy Inc.



www.usendoscopy.com

TRUTH Study

Click here to learn about the TRUTH1 Study.
Reference 1. Maravilla KR, Smith MP, Vymazal J, Goyal M, Herman M, Baima JJ, Babbel R, Vaneckova M, Zižka J, Colosimo C, Urbańczyk-Zawadzka M, Mechl M, Bag AK, Bastianello S, Bueltmann E, Hirai T, Frattini T, Kirchin MA, Pirovano G. Are There Differences between Macrocyclic Gadolinium Contrast Agents for Brain Tumor Imaging? Results of a Multicenter Intraindividual Crossover Comparison of Gadobutrol with Gadoteridol (the TRUTH Study). AJNR Am J Neuroradiol. 2014 Oct 9. [Epub ahead of print]

Congress calendar

From June 10 to 14, 2016
Seattle, WA

ASE

From June 11 to 15, 2016
San Diego, CA

SNMMI

Educational Events

AIMS

Established to compare various clinical approaches for targeted diagnostic imaging.

Read more

BAMRIS

Designed to help physicians stay abreast of the latest changes and applications in magnetic resonance.

Read more